These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Characterization of IGH rearrangements in non-Hodgkin's B-cell lymphomas by fluorescence in situ hybridization. Bernicot I; Douet-Guilbert N; Le Bris MJ; Morice P; Abgrall JF; Berthou C; Morel F; De Braekeleer M Anticancer Res; 2005; 25(5):3179-82. PubMed ID: 16101124 [TBL] [Abstract][Full Text] [Related]
4. Lack of PAX5 rearrangements in lymphoplasmacytic lymphomas: reassessing the reported association with t(9;14). Cook JR; Aguilera NI; Reshmi-Skarja S; Huang X; Yu Z; Gollin SM; Abbondanzo SL; Swerdlow SH Hum Pathol; 2004 Apr; 35(4):447-54. PubMed ID: 15116325 [TBL] [Abstract][Full Text] [Related]
5. Diffuse large B-cell lymphoma carrying t(9;14)(p13;q32)/PAX5-immunoglobulin heavy chain gene is characterized by nuclear positivity of MUM1 and PAX5 by immunohistochemistry. Ohno H; Nakagawa M; Kishimori C; Fukutsuka K; Maekawa F; Takeoka K; Hayashida M; Sakamoto S; Akasaka T; Honjo G Hematol Oncol; 2020 Apr; 38(2):171-180. PubMed ID: 31955451 [TBL] [Abstract][Full Text] [Related]
6. Chromosomal rearrangement of the PAX-5 locus in lymphoplasmacytic lymphoma with t(9;14)(p13;q32). Iida S; Rao PH; Ueda R; Chaganti RS; Dalla-Favera R Leuk Lymphoma; 1999 Jun; 34(1-2):25-33. PubMed ID: 10350329 [TBL] [Abstract][Full Text] [Related]
7. Molecular cytogenetics of IGH rearrangements in non-Hodgkin B-cell lymphoma. Bernicot I; Douet-Guilbert N; Le Bris MJ; Herry A; Morel F; De Braekeleer M Cytogenet Genome Res; 2007; 118(2-4):345-52. PubMed ID: 18000389 [TBL] [Abstract][Full Text] [Related]
8. Expression of the PAX5/BSAP transcription factor in haematological tumour cells and further molecular characterization of the t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma. Hamada T; Yonetani N; Ueda C; Maesako Y; Akasaka H; Akasaka T; Ohno H; Kawakami K; Amakawa R; Okuma M Br J Haematol; 1998 Aug; 102(3):691-700. PubMed ID: 9722295 [TBL] [Abstract][Full Text] [Related]
9. [Primary ocular adnexal lymphoproliferative lesions: clinicopathologic features and genetic alterations]. Dong LN; Liu HG; Jin HS; Ye HT; Gao ZF; Zhou XG; Dong GH; Zhang DD; Gong LP Zhonghua Bing Li Xue Za Zhi; 2008 Dec; 37(12):809-14. PubMed ID: 19159526 [TBL] [Abstract][Full Text] [Related]
10. Deregulated PAX-5 transcription from a translocated IgH promoter in marginal zone lymphoma. Morrison AM; Jäger U; Chott A; Schebesta M; Haas OA; Busslinger M Blood; 1998 Nov; 92(10):3865-78. PubMed ID: 9808580 [TBL] [Abstract][Full Text] [Related]
11. An additional segment at 1p36 derived from der(18)t(14;18) in patients with diffuse large B-cell lymphomas transformed from follicular lymphoma. Nomura K; Kanda-Akano Y; Shimizu D; Okuda T; Yoshida N; Matsumoto Y; Nishida K; Taki T; Yokota S; Horiike S; Taniwaki M Ann Hematol; 2005 Jul; 84(7):474-6. PubMed ID: 15700138 [TBL] [Abstract][Full Text] [Related]
12. The t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma. Ohno H; Ueda C; Akasaka T Leuk Lymphoma; 2000 Feb; 36(5-6):435-45. PubMed ID: 10784387 [TBL] [Abstract][Full Text] [Related]
14. Oncogenic role of Pax5 in the T-lymphoid lineage upon ectopic expression from the immunoglobulin heavy-chain locus. Souabni A; Jochum W; Busslinger M Blood; 2007 Jan; 109(1):281-9. PubMed ID: 16968900 [TBL] [Abstract][Full Text] [Related]
15. New chromosome abnormalities and lack of BCL-6 gene rearrangements in Argentinean diffuse large B-cell lymphomas. Cerretini R; Noriega MF; Narbaitz M; Slavutsky I Eur J Haematol; 2006 Apr; 76(4):284-93. PubMed ID: 16519699 [TBL] [Abstract][Full Text] [Related]
16. Molecular cytogenetic analysis of chromosomal breakpoints in the IGH, MYC, BCL6, and MALT1 gene loci in primary cutaneous B-cell lymphomas. Hallermann C; Kaune KM; Gesk S; Martin-Subero JI; Gunawan B; Griesinger F; Vermeer MH; Santucci M; Pimpinelli N; Willemze R; Siebert R; Neumann C J Invest Dermatol; 2004 Jul; 123(1):213-9. PubMed ID: 15191563 [TBL] [Abstract][Full Text] [Related]
17. Concurrent translocation of BCL2 and MYC with a single immunoglobulin locus in high-grade B-cell lymphomas. Knezevich S; Ludkovski O; Salski C; Lestou V; Chhanabhai M; Lam W; Klasa R; Connors JM; Dyer MJ; Gascoyne RD; Horsman DE Leukemia; 2005 Apr; 19(4):659-63. PubMed ID: 15716988 [TBL] [Abstract][Full Text] [Related]
18. PAX5-positive plasma cell myeloma with t(9;14;11)(p13;q32;q13), a novel complex variant translocation of t(11;14)(q13;q32) and t(9;14)(p13;q32). Sato K; Sakai H; Kato M; Nishio Y; Tsuruoka Y; Uemura Y; Yokoi S; Saito T; Matsunawa M; Suzuki Y; Isobe Y; Inoue Y; Takahashi M; Miura I Int J Hematol; 2015 Jun; 101(6):608-11. PubMed ID: 25633778 [TBL] [Abstract][Full Text] [Related]
19. Cytomorphologic findings of B-cell lymphomas with concurrent IGH/BCL2 and MYC rearrangements (dual-translocation lymphomas). da Cunha Santos G; Ko HM; Saieg MA; Boerner SL; Lai SW; Bailey D; Geddie WR Cancer Cytopathol; 2011 Aug; 119(4):254-62. PubMed ID: 21560251 [TBL] [Abstract][Full Text] [Related]
20. The spectrum of B-cell non-Hodgkin lymphomas with dual IgH-BCL2 and BCL6 translocations. Keller CE; Nandula S; Fisher J; Subramaniyam S; Vakiani E; Savage DG; Murty VV; Alobeid B; Bhagat G Am J Clin Pathol; 2008 Aug; 130(2):193-201. PubMed ID: 18628087 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]